Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis

References

• Sieni E, Cetica V, Hackmann Y, et al. Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning. Front Immunol. 2014;5:167.
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol Mech Dis. 2018;13(1):27–49.
   PubMedGoogle Scholar
• Henter JI, Horne A, Aricó M, et al. HLH‐2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Daver N, Kantarjian HM, Eby CS. Diagnostic challenges of hemophagocytic lymphohistiocytosis. Clin Lymphoma Myeloma Leukemia. 2017;17:S105–S110.
   Web of Science ®Google Scholar
• Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int. 2016;58(9):817–825.
   PubMed Web of Science ®Google Scholar
• Astigarraga I, Gonzalez-Granado L, Allende L, Alsina L. Haemophagocytic syndromes: The importance of early diagnosis and treatment. Anales de Pediatria. 2018;89(2):124.e1–124.e8.
   Web of Science ®Google Scholar
• Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol. 2017;49:20–26.
   PubMed Web of Science ®Google Scholar
• Riad El Fakih, Said Y. Mohamed, Randa Alnounou, Ghada Elgohary, Secondary HLH case report highlighting clinical challenges. Case Reports in Hematology. 2018; vol. 2018, Article ID 1913938, https://doi.org/10.1155/2018/1913938.
   Google Scholar
• Li W, Zhong Y, Shuang Y, et al. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. CBM. 2017;20(2):159–164.
   Google Scholar
• Goel S, Polski JM, Imran H. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Ann Clin Lab Sci. 2012;42(1):21–25.
   PubMed Web of Science ®Google Scholar
• Marsh RA. Epstein–Barr virus and hemophagocytic lymphohistiocytosis. Front Immunol. 2018;8:1902.
   PubMed Web of Science ®Google Scholar
• Krupka JA, Samelska K, Tomasik A, Stelmaszczyk-Emmel A, Pawelec K. Infectious mononucleosis-like syndrome with high lymphocytosis and positive IgM EBV and CMV antibodies in a three-year-old girl. CEJOI. 2017;42(2):210–212.
   Google Scholar
• Wang X, Yang K, Wei C, Huang Y, Zhao D. Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis. Virol J. 2010;7(1):247.
   PubMedGoogle Scholar
• Censoplano N, Gorga S, Waldeck K, Stillwell T, Rabah-Hammad R, Flori H. Neonatal adenovirus infection complicated by hemophagocytic lymphohistiocytosis syndrome. Pediatrics 2018;141(Supplement 5):S475–S480.
   PubMedGoogle Scholar
• Esteban YM, de Jong JL, Tesher MS. An overview of hemophagocytic lymphohistiocytosis. Pediatr Ann. 2017;46(8):e309–e313.
   PubMed Web of Science ®Google Scholar
• Pekpak E, Cetin BS. Secondary Hemophagocytic Lymphohistocytosis in a Child With Brucellosis. J Pediatr Hematol/Oncol. 2017;39(8):e501–e503.
   PubMed Web of Science ®Google Scholar
• Yaman Y, Gözmen S, Özkaya AK, et al. Secondary hemophagocytic lymphohistiocytosis in children with brucellosis: report of three cases. J Infect Dev Ctries. 2015;9(10):1172–1176.
   PubMed Web of Science ®Google Scholar
• Singh Z, Rakheja D, Yadav T, Shome D. Infection‐associated haemophagocytosis: the tropical spectrum. Clin Lab Haematol. 2005;27(5):312–315.
   PubMedGoogle Scholar
• Mokhtari M, Kumar PV. Visceral leishmaniasis-associated hemophagocytosis: a single center experience. Arch Iran Med. 2013;16(8):471.
   PubMed Web of Science ®Google Scholar
• Miyabayashi H, Kumaki S, Sato A, et al. Onset of hemophagocytic lymphohistiocytosis during piperacillin-tazobactam therapy in three children with acute focal bacterial nephritis. Tohoku J Exp Med. 2018;245(1):55–59.
   PubMed Web of Science ®Google Scholar
• Cardoso CS, Vieira AM, Oliveira AP. DRESS syndrome: a case report and literature review. BMJ Case Rep. 2011;3:bcr0220113898.
   Google Scholar
• Liang J, Qu H, Wang X, et al. Drug reaction with eosinophilia and systemic symptoms associated with reactivation of Epstein-Barr virus and/or cytomegalovirus leading to hemophagocytic syndrome in one of two patients. Ann Dermatol. 2018;30(1):71–74.
   PubMed Web of Science ®Google Scholar
• Picard M, Fernandez MI, Des Roches A, et al. Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol.. 2013;1(4):409–412. e402.
   Web of Science ®Google Scholar
• Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588–597.
   PubMed Web of Science ®Google Scholar
• Atteritano M, David A, Bagnato G, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci. 2012;16(10):1414–1424.
   PubMed Web of Science ®Google Scholar
• Singh S, Chandrakasan S, Ahluwalia J, et al. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. Rheumatol Int. 2012;32(4):881–886.
   PubMed Web of Science ®Google Scholar
• García-Pavón S, Yamazaki-Nakashimada MA, Báez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol/Oncol. 2017;39(6):445–451.
   PubMed Web of Science ®Google Scholar
• Choi JE, Kwak Y, Huh JW, et al. Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide. Korean J Pediatr. 2018;61(5):167–173.
   PubMedGoogle Scholar
• Veerakul G, Sanpakit K, Tanphaichitr VS, Mahasandana C, Jirarattanasopa N. Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome. J Med Assoc Thailand 2002;85:S530–S541.
   PubMedGoogle Scholar
• Strenger V, Merth G, Lackner H, et al. Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents—a single centre experience of 20 years. Ann Hematol. 2018;97(6):989–998.
   PubMed Web of Science ®Google Scholar
• Bin Q, Gao J-H, Luo J-M. Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases. Ann Hematol. 2016;95(9):1411–1418.
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Kim JH, Lee JS, Ryu J-M, Seo JJ, Im HJ. Initial characteristics and clinical severity of hemophagocytic lymphohistiocytosis in pediatric patients admitted in the Emergency Department. Pediatr Emerg Care. 2018;1.
   PubMedGoogle Scholar
• Zeng X, Wei N, Wang Y, et al. Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Zhonghua Xue ye Xue za Zhi 2015;36(6):507–510.
   PubMedGoogle Scholar
• Dumancas CY, Reyes HAG, Cosico J, Savadkar A, Lah S. Streptococcus pneumoniae-related hemophagocytic lymphohistiocytosis treated with intravenous immunoglobulin (IVIG) and steroids. Am J Case Rep. 2018;19:25–28.
   PubMed Web of Science ®Google Scholar
• Hernández-Jiménez P, Díaz-Pedroche C, Laureiro J, Madrid O, Martín E, Lumbreras C. Hemophagocytic lymphohistiocytosis: analysis of 18 cases. Med Clín (English Edition). 2016;147(11):495–498.
   Google Scholar
• Demirkol D, Yildizdas D, Bayrakci B, et al. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?. Crit Care. 2012;16(2):R52.
   PubMed Web of Science ®Google Scholar
• Xu XJ, Wang HS, Ju XL, et al. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study. Pediatr Blood Cancer. 2017;64(4):e26264.
   Web of Science ®Google Scholar
• Oh GH, Chung SP, Park YS, et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. Shock 2017;47(3):323–330.
   PubMed Web of Science ®Google Scholar